Vera Therapeutics GAAP EPS of -$1.20 misses by $0.50

15 hours ago 1

Vera Therapeutics press release (NASDAQ:VERA): Q2 GAAP EPS of -$1.20 misses by $0.50.
Vera reported $556.8 million in cash, cash equivalents, and marketable securities as of June 30, 2025, which combined with its undrawn debt facility, Vera believes to be sufficient to fund operations through potential

Recommended For You